Market Entry Intelligence Book Review: Navigating FDA Regulation to Build Scalable Global Brands

Most business books talk about growth like it’s a sprint. Faster entry, faster scale, faster wins. What Carlos Bisio argues in “Market Entry Intelligence: FDA, Regulation and Growth Strategy for International Companies” is almost the opposite and honestly, it’s a relief.

His core point is simple but uncomfortable: entering the U.S. market isn’t really a sales decision, it’s a governance decision. That shift in thinking sets the tone for the entire book. Right away, Bisio challenges assumptions that get international companies into trouble, like believing success at home will magically transfer to the U.S., or assuming distributors will somehow “take care of compliance.” They won’t and in the U.S., responsibility always lands back on the brand, whether you like it or not.

What makes this book work is that it doesn’t read like a regulatory textbook. It feels more like an executive briefing from someone who’s seen the damage up close. Bisio explains how agencies like the FDA, CBP, FTC and even digital platforms quietly decide who gets access, who looks credible, and who can actually scale. Regulation, as he frames it, isn’t red tape. It’s a trust system. Learn how it works, and things move faster. Ignore it, and everything eventually grinds to a halt.

The writing is another strong point. Bisio clearly knows his subject, but he doesn’t talk down to the reader. He mixes strategy with stories that feel a little too real- delayed shipments, frozen Amazon listings, internal teams working at cross purposes. You start to see how tiny oversights in labeling, formulation, or documentation can snowball into expensive, reputation-damaging problems.

The pacing is deliberate, and that’s intentional. Each section builds on the last, reinforcing the idea that compliance, operations, marketing, and leadership can’t be treated as separate lanes. One of the most valuable themes is executive awareness. Bisio isn’t asking CEOs to memorize regulations. He’s asking them to understand risk patterns well enough to ask smarter questions before something breaks.

If there’s one takeaway that sticks, it’s this: companies don’t fail in the U.S. because their products are bad. They fail because they misread the terrain. With the right preparation, regulatory discipline doesn’t slow growth, it stabilizes it.

This book is especially useful for international founders, executives, regulatory advisors, and growth teams either preparing for U.S. expansion or cleaning up after a painful attempt. It’s also a solid choice for anyone who wants strategic clarity without getting buried in legal jargon.

The book is practical, grounded, and clearly shaped by real-world experience. “Market Entry Intelligence” is less about avoiding mistakes and more about building a durable advantage through understanding how the U.S. market actually works.

Amazon link: https://www.amazon.com/dp/B0G6BC2N83?